Eesti - eesti - Ravimiamet

bausch + lomb ireland limited - brinsolamiid - silmatilgad, suspensioon - 10mg 1ml 5ml 3tk

Eesti - eesti - Ravimiamet

laboratorios liconsa s.a. - irbesartaan - tablett - 300mg 56tk; 300mg 28tk; 300mg 98tk

Eesti - eesti - Ravimiamet

medis ehf. - irbesartaan - õhukese polümeerikattega tablett - 75mg 28tk

Eesti - eesti - Ravimiamet

medis ehf. - irbesartaan - õhukese polümeerikattega tablett - 150mg 28tk

Eesti - eesti - Adama

adama - vees dispergeeruvad graanulid - metribusiin - herbitsiidid

Euroopa Liit - eesti - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - mitu müeloomit - antineoplastilised ained - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapoon - parkinsoni tõbi - parkinsoni tõve ravimid - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Eesti - eesti - Ravimiamet

il-csm clinical supplies management gmbh - koolera tekitaja, elus, nõrgestatud - suukaudse suspensiooni kihisev pulber ja pulber - 1annus 1tk

Eesti - eesti - Ravimiamet

takeda gmbh - dengue palaviku tekitaja, elus, nõrgestatud - süstelahuse pulber ja lahusti süstlis - 1annus 0.5ml 0.5ml 1tk; 1annus 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

viatris limited - klopidogreel-besilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombootilised ained - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmendi elevatsiooniga ägeda müokardi infarkti korral kombinatsioonis asa on meditsiiniliselt ravitud patsientide abikõlblikud trombolüütiline ravi. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. täiendava teabe jaoks vt osa 5.